Identification of flavonoids and hydroxycinnamic acids in polysaccharide-containing mixed herbal product (Pectorales species No 1) by Ultra-Performance Liquid Chromatography with Photodiode arrays and Tandem quadrupole Mass-selective detectors
Kakhramanova S.D.1,2*, Bokov D.O.1,3, Luferov A.N. 1, Samylina I.A.1, Rendyuk T. D. 1,
Sergunova E.V. 1, Bondar A.A.1, Fedorova L. V. 1, Klyukina E.S.1, Malysheva M.O.1,
Tikhomirova E.A.1, Baeva V.M. 1, Stepanova O.I.1, Yakubovich L.M.1, Selifanov A.V.3,
Bessonov V.V.3
1Sechenov First Moscow State Medical University, Institute of Pharmacy,
Department of Pharmaceutical Natural Science. Russian Federation.
2Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products”.
Russian Federation.
3Federal Research Center of Nutrition, Biotechnology and Food Safety, Russian Federation.
*Corresponding Author E-mail: ksd113@yandex.ru
ABSTRACT:
The pectoral species No 1 (phytopectol No 1) is widely used in Russian medicinal practice. Pectoral species No 1 (PS No 1) contains coltsfoot leaves (Tussilaginisfarfarae folia), marshmallow roots (Althaeae radices), oregano herb (Origani vulgaris herba). This research aims to determine the flavonoid profile of PS No 1. These biologically active compounds (BAC) can have pharmacological effects such as antioxidant, antibacterial. The UPLC/PDA/MS/MS method was used for flavonoids’ determination. Chromatographic system: ultra-performance liquid chromatograph Waters Acquity (Waters Corporation, USA). Column: 2.1×150 mm Acquity UPLC BEH (Bridged Ethylene Hybrid) C18 (particle size – 1.7 µm). The column temperature and the injection volume were 35 °C and 5 µL, respectively. Mobile phase A – a mixture of water, acetonitrile, and formic acid (95:5:0.1). Mobile phase B – a mixture of acetonitrile and formic acid (100:0.1). A gradient program was used for elution. Results: The pectoral species No 1 was established to contain various flavonoids as apigenin 7-O-β-glucuronide, luteolin 7,4'-diglucuronide-3'-glycoside, luteolin 7-O-glucuronide, luteolin 7-O-[β-D-glucuronosyl-(1→2)-β-D-glucuronide]-4'-O-β-D-glucuronide, rutin. Some derivatives of hydroxycinnamic acid such as caffeic acid, chlorogenic and isochlorogenic acids, isochlorogenic acid C (4,5-dicaffoylquinic acid), isochlorogenic acid A (3,5-dicaffoylquinic acid), 3,4,5-tricaffoylquinic acid were also identified in the herbal tea. Conclusions: The polyphenolic complex of pectoral species No. 1 was described; it was rich in flavonoids (flavonols and flavones) and hydroxycinnamic acid derivatives. The reported anti-inflammatory effect of the mixture herbal product (herbal tea) might be due to high flavonoid content. Thus, we recommend the flavonoids to be chosen as an active marker for the standardization of pectoral species No 1.
KEYWORDS: Flavonoids, hydroxycinnamic acids, polysaccharides, Origanum vulgare L., Tussilagofarfara L., Althaea officinalis L., pectoral species No 1, apigenin, luteolin, kaempferol, quercetin.
INTRODUCTION:
The mixed herbal products (MHP) or herbal teas (HP), being polyherbal formulations1-6, have been widely used for the complex treatment of bronchopulmonary system diseases. The pectoral species No 1 (Phytopectol No. 1 (Pectorales species No. 1 (PS No. 1) is one of these herbal products and according to the project of the pharmacopoeial monograph (PM) it is composed of 40% marshmallow roots (dried roots from Althaea officinalis L. or A. armeniaca Ten., Fam. Malvaceae), 40% coltsfoot leaves (dried leaves from Tussilagofarfara L., Fam Asteraceae) and 20% oregano herb (dried aerial parts of Origanum vulgare L., Fam. Lamiaceae). According to the instructions for use, PS No 1 refers to the expectorants of plant origin pharmacological groups; its infusion has an expectorant as well as an anti-inflammatory effect. PS No. 1 is a mixture of heterogeneous particles of plant material; it has a greenish-gray color with white, grayish-white, greenish-brown, brown, and violet inclusions (Figure 1). The smell is weak, fragrant; the taste of the aqueous extract is spicy, with a sensation of mucus.
Figure 1. Phytopectol No. 1 (Pectorales species No. 1)
It is known that the main group of PS No 1 biologically active compounds (BAC) is polysaccharides. Insufficient attention was paid to the study of the PS No 1 component composition despite its fame and popularity. Currently, there are pharmacopoeial monographs (PM) on the individual components of the MHP; normative documentation (ND) regulating the quality of the PS No 1 itself requires revision. For the normative documentation improvement, it is necessary to know the composition of all PS No 1 BAС groups that have a pharmacological effect, including flavonoids.
There is information for the crude herbal drugs flavonoid profile in PS No 1. So, the main flavonoids of Origanum vulgare L. herb have been reported to be apigenin, luteolin, and their glycosides7-10. Also, some hydroxycinnamic acid derivatives have been identified in the oregano herb9, as well. The literature data have shown that the roots of Althaea officinalis L. contain caffeic acid and isoscutellarin flavone12, while coltsfoot leaves contain kaempferol and quercetin glycosides13. There are no data about flavonoids in Althaea armeniaca L. roots.
Researchers from different countries studied the pharmacological activity of coltsfoot leaves, marshmallow roots, and oregano herb. Research data are presented in Table 1.
The aim of the present work was the determination of the main polyphenol complex compounds, particularly flavonoids, in pectoral species No 1.
Table 1. PS No 1 components’ pharmacological activity
Extract |
The main BAS group, compound |
Biological/ pharmacological effect |
|
Coltsfoot leaves (Folia tussilaginisfarfarae) |
|||
Fractionated extract, Fermented extract |
kaempferol 3-O-[3,4-O-(isopropylidene)-α-L-arabinopyranoside] |
Hypoglycemic effect14 |
|
Ethanol extract |
Flavonoids: rutin, quercetinpentoside, quercetin glycoside, kaempferol glycoside, tricaffeoylquinic acid, quinic acid, chlorogenic acid |
Antioxidant activity; Antimicrobial activity29 |
|
Marshmallow roots (Radices althaeae) |
|||
Aqueous extracts |
The total amount of phenolic compounds in terms of gallic acid |
Antimicrobial activity16 |
|
Aqueous extracts |
Hydrophilic compounds |
Antiproliferative effect; Decreased cisplatin-induced aberration17 |
|
polysaccharide-depleted methanol-water (1:1) extract |
Flavons: hypolaetin-8-O-β-D-glucuronopyranosyl-1''',4''-β-O-D-glucopyranoside, hypolaetin-4'-methlyether-8-O-β-D-glucopyranoside-2″-O-sulfate, hypolaetin-8-O-β-D-glucopyranoside-2″-O-sulfate, hypolaetin-4'-methylether-8-O-β-D-glucuronopyransoide-3″-O-sulfate, isoscutellarein-4'-methlyether-8-O-β-D-glucuronopyransoide-3″-O-sulfate; Cumarin: scopoletin-O-β-D-glucopyranosyl-L-rhamnoside |
Anti-inflammatory effect18 |
|
Ethanol extract |
quercetin, rutin, apigenin, isorhamnetin, scopoletin, coumarins, kaempferol |
antioxidant, antitumor, antibacterial, cardioprotective, anti-inflammatory immunomodulatory effects19 |
|
Aqueous extract, methanol extract |
rhamnogalacturonan |
Bronchodilator effect, β-adrenergic effect25 |
|
Alcoholic extract |
The total amount of phenolic compounds
|
Hypolipidemic effect26 |
|
Oregano herb (Herbaorigani vulgaris) |
|||
Alcoholic extract, essential oils |
polyphenolic compounds. terpenes: thymol, carvacrol |
Antioxidant effect (suppression of the destructive effect of diazinon on the body)20 |
|
Essential oils |
Terpenes: α-thujene, myrcene, α-terpinene, o-cymen, γ-terpinene, thymol, carvacrol |
Antioxidant activity21 |
|
Essential oils |
Terpenes: β-caryophyllene epoxide ‑ 13.3%; β-caryophyllene ‑ 8.2%; cymen‑ 5.2% Flavonoids: The sum of flavonoids in terms of catechin |
Antioxidant activity |
|
Essential oils |
Terpenes: α-pinene, α-thujene, camphene, α-terpinene, γ-terpinene, p-cymene, trans-linalol oxide, 1-octen-3-ol, cis-linalol oxide, linalool, hotrienol, β-caryophyllene, α-humulene, α-terpineol, borneol, β-bisabolene, p-cymene-8-ol, caryophyllene oxide, elemol, thymol, carvacrol |
Chelating ability |
|
Fractionated extract |
Hydroxycinnamic acids: rosmarinic acid, oleanolic acid, ursolic acid |
Tyrosinase inhibition; |
|
Aqueous extract, ethanol extract |
Sum of biologically active compounds |
Antimicrobial activity22 |
|
Ethanol extract |
Hydroxycinnamic acids: rosmarinic acid, chlorogenic acid, p-coumaric acid, gentisic acid (2,5-dihydroxybenzoic acid); Flavonoids: hyperoside, isoquercetin, rutin, quercetin, quercetrin, luteolin |
Antioxidant activity |
|
MATERIALS AND METHODS
Plant material:
The pectoral species No 1 (Phytopectol No 1, Pectorales species No 1; JSC “Krasnogorskleksredstva”) samples were purchased in Moscow Pharmacy Network. The samples corresponded to the requirements of State Pharmacopoeia of Russian Federation (SPRF) XIV edition.
Sample preparation:
About 2.0 g (accurately weighed) of crushed PS No 1 (particle size passing through a 0.5 mm sieve) is placed in a 250 ml conical flask with a ground stopper, 50 ml of hexane is added. Flask is combined with a reflux condenser, heated in a water bath, maintaining a weak boil for 1 h. Then the flask is cooled to room temperature, the contents of the flask are filtered through a folded paper filter, discarding the hexane extract. The filter is placed back into the flask, the operation is repeated one more time with hexane, then 2 times with chloroform. Then 50 ml of 70% methanol is added the extraction procedure is repeated, the extract is collected in a 250 ml flask. The extraction is repeated twice more. The combined alcohol extract is evaporated on a rotary vacuum evaporator, dissolved in 5 ml of 70% methanol, filtered through a membrane filter (0,45 μm, Agilent Technologies, USA), and used for UPLC analysis.
Determination of flavonoids and hydroxycinnamic acids:
The PS No 1 extract was studied using an Acquity UPLC TQC system (Waters Corporation, USA). The system consists of ultra-performance liquid chromatography (UPLC) system and sequential quadrupole mass-spectrometry (MS/MS) with photodiode array (PDA) detectors. The UPLC chromatographic system contains a binary gradient pump, sample delivery systems (including a column heater), a photodiode array detector (Waters PDA, USA) and a triple quadrupole mass-spectrometric detector (Waters ACQUITY Triple Quadrupole Detector (TQD), USA). The MassLynx 4.1 program was used to process the experimental chromatographic data and to control the instruments.
Chromatography was run on Waters Acquity ultra-perfomance liquid chromatograph (Waters, USA). Mobile phase A was a mixture of water, acetonitrile, and formic acid (95:5:0.1). Mobile phase B was a mixture of acetonitrile and formic acid (100:0.1). The gradient elution was formed by mixing the mobile phase A and mobile phase B according to the gradient program: MPhА: - 95-50% (0-30 min), 50-0% (30-32 min), 0-95% (32-33 min), 95% (33-36 min); MPhВ: 5-50% (0-30 min), 50-100% (30-32 min), 100-5% (32-33 min), 5% (33-36 min). The mobile phase flow rate was 0.3 ml/min.
The separation was achieved on Acquity UPLC BEH (Bridged Ethylene Hybrid) C18 (150×2.1 mm, particle size 1.7 µm) chromatography column. The column temperature was 35 ⁰C. The sample volume was 5 µl. Conditions for UV detection: 220-550 nm. Conditions for MS/MS detection: TQD (Waters Corporation, USA) mass spectrometer operated in alternating positive and negative electrospray ionization (MS-ES+/-) regimes. Detector parameters in the positive and negative ion modes: Voltage on capillary - +3 kV (ES+), -3kV (ES–); Voltage on the nozzle - +50 V (ES+), -30 V (ES–); Capillary temperature +450 ⁰С (ES+), +350 ⁰С (ES–); Source temperature - +120 (ES+), +120 (ES–); Drying gas flow rate - 50 liters/h (ES+), 50 liters/h (ES–); Mass scanning range - from 100 to 1500 U (ES+), from 100 to 1500 U (ES–).
RESULTS AND DISCUSSION:
Chromatograms obtained during the pectoral species No 1 analysis are presented in Figure 2-14. In the positive ion mode, the protonated molecule with m/z = 446 was seen in the one peak with RT of 10.49 min (Figure 2).
Figure 2. Chromatogram and mass-spectrum of apigenin (m/z = 271) derivative (flavone) in the positive and negative ion mode
This component may be apigenin derivative, it may be apigenin 7-O-β-glucuronide. In the positive ion mode, the presence of the protonated molecule at m/z = 287 due to flavonoid aglycone was established in nine peaks at 5.87, 5.94, 7.99, 8.54, 9.17, 9.67, 10.27, 10.87 and 11.18 min. These components may be luteoline, kaempferol, and/or isoscutellarein derivatives (Figure 3).
Figure 3. Chromatogram of apigenin 7-O-β-glucuronide (retention time – 10.49 min) in the positive and NIM, wavelength 350 nm, m/z = 446 and flavonoids (luteolin, kaempferol, isoscutellarein derivatives; RT‑ 5.87, 5.94, 7.99, 8.54, 9.17, 9.67, 10.27, 10.87 and 11.18 min) in the positive ion mode, wavelength 350-370 nm, m/z = 287
The molecular ion m/z = 638 was seen in the two peaks with retention times of 5.87 and 5.94 min (Figure 4). These components may be luteolin derivatives.
Figure 4. Chromatogram and mass-spectra of flavonoids (luteolin derivatives; RT ‑ 5.87 and 5.94 min) in the positive and negative ion mode, wavelength 350-370 nm, m/z = 638
A protonated molecule at m/z = 800 appeared in a peak with RT of 7.99 min. This component may be luteolin 7,4’-diglucuronide-3’-glucoside (Figure 5).
Figure 5. Chromatogram and mass-spectra luteolin 7,4’-diglucuronide-3’-glycoside (RT‑ 7.99 min) in the positive and negative ion mode, wavelength 350-370 nm, m/z = 800
A protonated molecule at m/z = 462 was appeared in a peak with RT of 8.54 min. The component may be luteolin 7-O-glucuronide (Figure 6).
Figure 6. Chromatogram and mass-spectra of luteolin 7-O-glucuronide (RT‑ 8.54 min) in the positive and negative ion mode, wavelength 350-370 nm, m/z = 462
The molecular ion m/z = 814 was seen in the one peak with a retention time of 9.16 min. This component may be luteolin 7-O-[β-D-glucuronosil-(1→2)-β-D-glucuronide]-4’-О-β-D-glucuronide (Figure 7).
Figure 7. Chromatogram and mass-spectrum of luteolin 7-O-[β-D-glucuronosyl-(1→2)-β-D-glucuronide]-4'-O-β-D-glucuronide (RT 9.16 min) in the positive and NIM, wavelength 350-370 nm, m/z = 814
In the positive ion mode, the molecular ion m/z = 303 was seen in the four intensive peaks with RT of 7.75, 8.01, 8.22, and 9.16 min. These components may be quercetin derivatives.
The molecular ion m/z = 610 peak is seen in the one peak with a retention time 7.75 min. This component may be rutin (Figure 8).
Figure 8. Chromatogram and mass-spectrum of rutin (quercetin derivative; RT – 7.75 min) in the positive and negative ion mode, wavelength 350-360 nm, m/z = 610
In the positive ion mode, the molecular ion m/z = 354 was seen in the two peaks with RT of 3.68 and 3.78 min. These components may be chlorogenic and isochlorogenic acids (Figure 9).
Figure 9. Chromatograms and mass-spectra of chlorogenic and isochlorogenic acid (RT – 3.68 and 3.78 min) in the positive and negative ion mode, wavelength 240-330 nm, m/z = 354
In the positive ion mode, the molecular ion m/z = 516 was seen in the one peak with a retention time of 9.38 min. This component may be isochlorogenic acid C or 4,5-dicaffoylquinic acid (Figure 10).
Figure 10. Chromatograms and mass-spectra of isochlorogenic acid C and 4,5-dicaffoylquinic acid (retention time – 9.38 min) in the positive and negative ion mode, wavelength 240-350 nm, m/z = 516
The molecular ion [M + H] m/z = 516 was seen in the one peak with a retention time of 10.76 min (Fig. 11). This component may be isochlorogenic acid A or 3,5-dicaffoylquinic acid too. These chemical structures are isomers, so their output sequence can be reversed.
Figure 11.Chromatograms and mass-spectra of isochlorogenic acid A and 3,5-dicaffoylquinic acid (retention time – 10.76 min) in the positive and negative ion mode, wavelength 240-330 nm, m/z = 516
The molecular ion [M+H] m/z = 678, [M+H] m/z = 677 was seen in the one peak with a retention time of 14.81 min. This component may be 3,4,5-tricafeoylquinic acid (Figure 12).
Figure 12.Chromatogram and mass-spectrum of 3,4,5-tricafeoylquinic acid (retention time – 14.81 min) in the positive and negative ion mode, wavelength 240-330 nm, m/z = 677, m/z = 678
So, after the pectoral species No 1 extract UPLC/PDA/MS/MS analysis luteolin 7,4’-diglucuronide-3’-glucoside, luteolin 7-O-[β-D-glucuronosil-(1→2)-β-D-glucuronide]-4’-О-β-D-glucuronide, rutin, caffeic acid, isochlorogenic acid, chlorogenic acid, isochlorogenic acid C (4,5-dicaffoylquinic acid), isochlorogenic acid A (3,5-dicaffoylquinic acid), 3,4,5-tricaffoylquinic acid were determined. The literature data of PS No 1 determined flavonoids’ pharmacological activity is shown in Table 4.
Table 4. PS No 1 determined flavonoids’ pharmacological activity
Compound/component |
Pharmacological effects according to literature data |
Apigenin 7-O-β-glucuronide |
Antioxidant, anti-inflammatory, inhibition of ACHE, antitumor effects38 |
Luteolin 7,4’-diglucuronide-3’-glycoside |
Antioxidant, anti-inflammatory, antimicrobial, antitumor effects38 |
Luteolin 7-O-[β-D-glucopyranosyl-(1→2)-β-D-glucuronide]-4’-O-β-D-glucuronide |
Antioxidant, anti-inflammatory, antimicrobial, antitumor effects38 |
Rutoside |
antioxidant, cytoprotective, vasoprotective, anticarcinogenic, neuroprotective, cardioprotective, antidiabetic (hypoglycemic) effects30, 31 |
Caffeic acid |
Antimicrobial, immunomodulatory effects32, 33 |
Chlorogenic acid |
Antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, hypolipidemic, antiviral, antimicrobial, antihypertensive effects34 |
Isochlorogenic acid |
Anti-inflammatory, antioxidant effects37 |
4,5-Dicaffeoylquinic acid (Isochlorogenicacid C) |
Antiviral activity37 |
3,5-Dicaffeoylquinic acid (Isochlorogenicacid А) |
Anti-inflammatory, Antimicrobial, Antioxidant effects38 |
3,4,5-Tricaffeoylquinic acid |
Antiviral activity35 |
CONCLUSIONS:
The general tonic effect with a high degree of probability may be due to the antioxidant, anti-inflammatory, immunomodulatory effect of flavonoids and hydroxycinnamic acids, containing in pectoral species No. 1. Flavonoids are an important group of biologically active substances from the pharmacological point of view; also, the standardization of pectoral species No. 1 should be carried out by the total flavonoids content.
In this study apigenin, luteolin, kaempferol, quercetin derivatives were found in PS No 1: apigenin 7-O-β-glucuronide, luteolin 7,4'-diglucuronide-3'-glycoside, luteolin 7-O-glucuronide, luteolin 7-O-[β-D-glucuronosyl-(1→2)-β-D-glucuronide]-4'-O-β-D-glucuronide, rutin. The next hydroxycinnamic acids were also found in PS No 1: caffeic acid, chlorogenic and isochlorogenic acids, isochlorogenic acid C (4,5-dicaffoylquinic acid), isochlorogenic acid A (3,5-dicaffoylquinic acid), 3,4,5-tricaffoylquinic acid.
All of PS No 1 components contain rutin (quercetin derivative)18,27,14,39. Hydroxycinnamic acids are mostly in oregano herb25,27 and coltsfoot leaves14. There is no data about hydroxycinnamic acids presence in marshmallow roots.
ACKNOWLEDGEMENT:
The authors would like to express special gratitude to Nedialkov P.T. for his assistance in preparing this manuscript and valuable advice.
REFERENCES:
1. Tehseen F. Ghori SS. Dawood M. Tazeen S. Sara K., Samad A. Phytochemical Screening and Invitro Anthelmintic Activity of a Novel Polyherbal Formulation. Research Journal of Pharmacy and Technology. 2021; 14(5): 2742-4. https://doi.org/10.52711/0974-360X.2021.00483
2. Khan A. Siddiqui A. Jafri MA, Asif M. Pharmacognostical and Phytochemical Evaluation of Renowned Polyherbal Formulation, Sharbat Ahmad Shahi: A Comprehensive Approach with Modern Techniques. Research J. Pharm. and Tech. 2021; 14(1): 189-194. https://doi.org/10.5958/0974-360X.2021.00033.0
3. Patil SJ. Patil SD. Patil PB. Patil PS.Vambhurkar GB. Raut ID. Evaluation of Standardization Parameters of Ayurvedic Marketed Polyherbal Formulation. Asian J. Pharm. Ana. 2018; 8(4): 220-226. https://doi.org/10.5958/2231-5675.2018.00040.6
4. Naik BSK. Duganath N. Kumar SR. Devanna N. Extraction and Characterization of Hesperidine Present in Natural and Polyherbal Formulation. Asian J. Research Chem. 2013; 6(6): 531-535.
5. Raj B. Khanam S. John S. Madhavi T. Siddique A. Quantitative Estimation of Rosmarinic Acid in Ocimum sanctum Extracts and Polyherbal Formulation by HPTLC. Research J. Pharmacognosy and Phytochemistry 2010; 2(1): 46-48.
7. Hawas UW. El-Desoky SK.Kawashty SA. Sharaf M. Two new flavonoids from Origanum vulgare. Natural Product Research. 2008; 22(17):1540-3. https://doi.org/10.1080/14786410600898987
8. Bokov DO. Nizamova LA. Morokhina SL et al. Pharmacognostic studies of Origanum L. species Medicinal plant raw materials. Research Journal of Pharmacy and Technology. 2020; 13(9): 4365-4372. https://doi.org/10.5958/0974-360X.2020.00772.6
10. Nistane NT. Herbal Nanoparticles against Cancer. Res. J. Pharma. Dosage Forms and Tech. 2019; 11(4): 247-252. https://doi.org/10.5958/0975-4377.2019.00041.7
11. Zhang XL. Guo YS. Wang CH. Li GQ. Xu JJ. Chung HY et al. Phenolic compounds from Origanum vulgare and their antioxidant and antiviral activities. Food Chemistry. 2014;152:300-6. https://doi.org/10.1016/j.foodchem.2013.11.153
12. Gudej J. Flavonoids, phenolic acids and coumarins from the roots of Althaea officinalis. Planta Medica. 1991; 57(3): 284-5. https://doi.org/10.1055/s-2006-960092
14. Ferrer DB. Venskutonis PR.Talou T.Zebib B. Ferrer JMB et al. Identification and in vitro activity of bioactive compounds extracted from Tussilagofarfara (L.) Plant Grown in Lithuania and France. Free Radicals and Antioxidants. 2018; 8(1): 40-7. https://doi.org/10.5530/fra.2018.1.7
15. Haghgoo R. Mehran M.Afshari E. Zadeh HF.Ahmadvand M. Antibacterial effects of different concentrations of Althaea officinalis root extract versus 0.2% chlorhexidine and penicillin on Streptococcus mutans and Lactobacillus (in vitro). J of Int Society of Preventive and Community Dentistry. 2017; 7(4): 180. https://doi.org/10.4103/jispcd.JISPCD_150_17
16. Zhang Y. Kong F. Zhang L. Li C. Zhang R. Modulatory effect of Althaea officinalis L root extract on cisplatin-induced cytotoxicity and cell proliferation in A549 human lung cancer cell line. Tropical J of Pharm Res. 2016; 15(12): 2647-52. https://doi.org/10.4314/tjpr.v15i12.16
17. Sendker J.Böker I.Lengers I. Brandt S. Jose J. Abdel-Aziz H. et al. New flavonglucuronides, scopoletin glycosides from the roots of Althaea officinalis L. and anti-hyaluronidase-1 activity. Planta Medica. 2016;82(01):160. https://doi.org/10.1055/s-0036-1596320
18. Kadhum HH. Abd AH. Al-Shammari AM. HPLC analysis and chemical composition identification of isolated flavonoid fraction of Althaea officinalis from Iraq. In AIP Conference Proceedings AIP Publishing LLC. 2019; 2123(1): 020045. https://doi.org/10.1063/1.5116972
19. Alani B.Zare M.Noureddini M. Bronchodilatory and B-adrenergic effects of methanolic and aqueous extracts of Althaea root on isolated tracheobronchial smooth rat muscle. Advanced Biomedical Research. 2015; 4: 78. https://doi.org/10.4103/2277-9175.153905
21. Rafieepour A.Hajirezaee S. Rahimi R. Moderating effects of dietary oregano extract (Origanum vulgare) on the toxicity induced by organophosphate pesticide, diazinon in rainbow trout, Oncorhynchusmykiss: metabolic hormones, histology and growth parameters. Turkish Journal of Fisheries and Aquatic Sciences. 2019; 20(3):207-19. http://doi.org/10.4194/1303-2712-v20_3_05
22. Stanojević LP.Stanojević JS.Cvetković DJ.Ilić DP. Antioxidant activity of oregano essential oil (Origanum vulgare L.). Biologica Nyssana. 2016; 7(2): 131-9. http://doi.org/10.5281/zenodo.200410
23. Moghrovyan A. Sahakyan N. Babayan A.Chichoyan N.Petrosyan M. et al. Essential oil and ethanol extract of oregano (Origanum vulgare L.) from Armenian flora as a natural source of terpenes, flavonoids and other phytochemicals with antiradical, antioxidant, metal chelating, tyrosinase inhibitory and antibacterial activity. Current Pharmaceutical Design. 2019; 25(16): 1809-16. https://doi.org/10.2174/1381612825666190702095612
24. Sarikurkcu C.Zengin G.Oskay M.Uysal S. Ceylan R. et al. Composition, antioxidant, antimicrobial and enzyme inhibition activities of two Origanum vulgare subspecies (subsp. vulgare and subsp. hirtum) essential oils. Industrial Crops and Products. 2015; 70: 178-84. https://doi.org/10.1016/j.indcrop.2015.03.030
25. Shen D. Pan MH. Wu QL. Park CH.Juliani HR. et al. LC-MS method for the simultaneous quantitation of the anti-inflammatory constituents in oregano (Origanumspecies). Journal of Agricultural and Food Chemistry. 2010; 58(12): 7119-25. https://doi.org/10.1021/jf100636h
26. Beltrán JMG. Espinosa C. Guardiola FA. Esteban MÁ. In vitro effects of Origanum vulgare leaf extracts on gilthead seabream (Sparusaurata L.) leucocytes, cytotoxic, bactericidal and antioxidant activities. Fish and Shellfish Immunology. 2018;79:1-10. https://doi.org/10.1016/j.fsi.2018.05.005
27. Oniga I.Pușcaș C.Silaghi-Dumitrescu R.Olah NK.Sevastre B. et al. Origanum vulgare ssp. vulgare: Chemical composition and biological studies. Molecules. 2018; 23(8): 2077. https://doi.org/10.3390/molecules23082077
28. Salehi B.Venditti A. Sharifi-Rad M.Kręgiel D. Sharifi-Rad J. et al. The therapeutic potential of apigenin. Int J of Molec Sci. 2019; 20(6): 1305. https://doi.org/10.3390/ijms20061305
29. Kittiratphatthana N.Kukongviriyapan V.Prawan A.Senggunprai L. Luteolin induces cholangiocarcinoma cell apoptosis through the mitochondrial‐dependent pathway mediated by reactive oxygen species. J of Pharmacy and Pharmacology. 2016; 68(9): 1184-92. https://doi.org/10.1111/jphp.12586
30. Ghorbani A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomedicine and Pharmacotherapy. 2017; 96: 305-12. https://doi.org/10.1016/j.biopha.2017.10.001
31. Ganeshpurkar A. Saluja AK. The pharmacological potential of rutin. Saudi Pharmaceut. J. 2017; 25: 149-64. https://doi.org/10.1016/j.jsps.2016.04.025
32. Lima VN. Oliveira-Tintino CD. Santos ES.Morais LP.Tintino SR. et al. Antimicrobial and enhancement of the antibiotic activity by phenolic compounds: Gallic acid, caffeic acid and pyrogallol. Microbial Pathogenesis. 2016; 99: 56-61. https://doi.org/10.1016/j.micpath.2016.08.004
33. Armutcu F. Akyol S.Ustunsoy S. Turan FF. Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects. Experimental and Therapeutic Medicine. 2015; 9(5): 1582-8. https://doi.org/10.3892/etm.2015.2346
34. Naveed M. Hejazi V. Abbas M. Kamboh AA. Khan GJ. et al. Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomedicine and Pharmacotherapy. 2018; 97: 67-74. https://doi.org/10.1016/j.biopha.2017.10.064
35. Du KZ. Li J. Guo X. Li Y. Chang YX. Quantitative analysis of phenolic acids and flavonoids in CuscutaChinensis Lam. by synchronous ultrasonic-assisted extraction with response surface methodology. Journal of Analytical Methods in Chemistry. 2018; 1: 1-10. https://doi.org/10.1155/2018/6796720
36. Cao Z. Ding Y. Cao L. Ding G. Wang Z. et al. Isochlorogenic acid C prevents enterovirus 71 infection via modulating redox homeostasis of glutathione. Sci Rep. 2017; 7(1): 1-10. https://doi.org/10.1038/s41598-017-16446-7
37. Wang J. Cao G. Wang H. Ye H. Zhong Y. et al. Characterization of isochlorogenic acid A metabolites in rats using high‐performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry. Biomedical Chromatography. 2017; 31(8): 3927. https://doi.org/10.1002/bmc.3927
38. Tamura H.Akioka T. Ueno K.Chujyo T. Okazaki KI. et al. Anti‐human immunodeficiency virus activity of 3,4,5‐tricaffeoylquinic acid in cultured cells of lettuce leaves. Molecular Nutrition and Food Research. 2006; 50(4‐5): 396-400. https://doi.org/10.1002/mnfr.200500216
39. Dhanashri Aware. Sachin Rohane. A Role of Herbal Drug as an Immunity Booster during COVID-19 Pandemic. Asian Journal of Pharmaceutical Research. 2021; 11(3): 206-1. https://doi.org/10.52711/2231-5691.2021.00037
Received on 24.02.2024 Revised on 04.06.2024 Accepted on 28.08.2024 Published on 24.12.2024 Available online from December 27, 2024 Research J. Pharmacy and Technology. 2024;17(12):5779-5789. DOI: 10.52711/0974-360X.2024.00879 © RJPT All right reserved
|